Drug Shortages: Impact and Strategies

Author: Philip E. Johnson MS, RPh, FASHP
View More View Less

Philip Johnson, MS, RPh, FASHP, is the founding Director of Pharmacy at the Moffitt Cancer Center in Tampa, Florida, and is currently the Pharmacy Advocacy Director. His accomplishments at Moffitt include developing and implementing numerous treatment guidelines, a hospital-wide research department, research committee, ethics committee, and ASHP-certified oncology specialty residency. During his career he has opened 3 new hospitals where he developed patient focused, multidisciplinary, clinical pharmacy services.

Mr. Johnson is a founding Director of the Florida Cancer Pain Initiative (FCPI), and the Hematology Oncology Pharmacy Association (HOPA) which he served as President in 2009. He chaired the NCCN workgroup on REMS, and chairs the ISMP taskforce to develop an international oncology medication self assessment tool. He represents ASHP on the AHA Committee on Professions, and is on the ASHP Foundation PLA faculty. Mr. Johnson is the pharmacist representative to the Florida School Health and Education Consortium (SHEC) where he focuses on medication safety and compliance in the Florida public school system, an effort that won an ISMP Cheers Award.

The ideas and viewpoints expressed in this editorial are those of the author and do not necessarily represent any policy, position, or program of NCCN.

  • 1

    Kavilanz P. Drug shortages at all-time high. CNN Money. Available at http://money.cnn.com/2011/06/10/news/economy/drug_shortages_fda/index.htm?iid=H_E_News. Published 10 June 2011. Accessed 5 July 2011.

    • Search Google Scholar
    • Export Citation
  • 2

    Alazraki M. Drug shortages: a deadly problem with no cure in sight. Daily Finance. Available at www.dailyfinance.com/2011/01/11/drug-shortages-a-deadly-problem-with-no-cure-in-sight/. Published 11 January 2011. Accessed 5 July 2011.

    • Search Google Scholar
    • Export Citation
  • 3

    Preserving access to life-saving medications act, S 296, 112th Cong (2011). Available at http://www.govtrack.us/congress/bill.xpd?bill=s112-296.

    • Search Google Scholar
    • Export Citation
  • 4

    Jensen V, Kimzey LM, Goldgerger MJ. FDA's role in responding to drug shortages. Am J Health Practitioner 2002;59:14231425.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 405 83 6
PDF Downloads 126 52 5
EPUB Downloads 0 0 0